IMNN (Imunon, Inc.) Expected net earnings per share growth this year

Corporate emblem and logo of Imunon, Inc. (IMNN)

The investment potential of Imunon, Inc. (IMNN) is based on the success of the PlaCCine platform and survival data for ovarian cancer patients. The percentage deviation of EPS from last year's level visualizes profit dynamics, where the indicator stands at 64.10. Prospects are bolstered by the development of DNA immunotherapy to combat infections, although geopolitical tensions and logistics challenges regarding components from Asia create certain risks.

IMNN - Celsion Corporation Earnings growth in current year over the range 04/28/2023 - 11/15/2026

Financial and market metric breakdowns for Imunon, Inc. (IMNN)

- stock price and consensus target price:
Price Performance Chart Imunon Inc|IMNN - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Imunon, Inc.|IMNN - Total Company Value
- shareholders' equity book value data:
Equity per Share Imunon|IMNN - Book Capitalization|Market Cap to Net Assets Ratio imunon.com|IMNN - Cumulative Company Assets
- debt and liquidity details:
Total Debt to Capital Coefficient Imunon, Inc.|IMNN - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Celsion Corporation|IMNN - Company Debts|Debt to Book Value Imunon, Inc.|IMNN - Company Long-Term Debt|Company Short-Term Indebtedness Imunon|Immediate Liquidity Ratio imunon.com
- earnings and market ratios statistics:
IMNN - Net Profit|Net Profit Forecast Imunon, Inc.|IMNN - Price to Earnings Ratio|Price to Future Earnings Ratio Imunon Inc|IMNN - PEG Multiple|EV/EBITDA Multiple Imunon|IMNN - Operating profit EBITDA|Net earnings per share for the last four quarters Imunon|IMNN - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months imunon.com|IMNN - Net earnings per share growth this year|Earnings growth forecast for next year Imunon, Inc.
- sales volume and revenue information:
IMNN - Company Revenue|Company Revenue Forecast Celsion Corporation|IMNN - Price-to-Revenue Ratio|Market Cap to Future Revenue Ratio Imunon, Inc.|IMNN - Sales Growth YoY (Last Twelve Months)
Basic company analysis:IMNN, imunon.com
Mass-produced product of Celsion Corporation

Fundamental asset selection requires an analysis of net profit per share dynamics. This indicator measures the annual percentage change in EPS, revealing capital management efficiency and profitability. For Imunon, Inc. (IMNN), this metric reflects management's ability to convert grant funding for the Placcine platform into financial results. Analyzing annual EPS progress allows for an assessment of the biotech's resilience during the clinical trial stage.

Main competitors

Tempus AI, Inc (TEM) - Earnings growth in current year|Earnings per share growth in current year Qiagen|IONS: Earnings per share increase in current year|Net earnings per share growth this year RGEN (Repligen)|Expected net earnings per share growth this year Avidity Biosciences Inc|Earnings growth in current year CRSP (crisprtx.com)|WGS: Earnings per share growth this year|RARE: Net earnings per share growth this year|Earnings per share trend in current year BEAM|Sarepta (SRPT) - Earnings per share growth in current year|TWST - Expected net earnings per share growth this year|Earnings per share growth in current year 10x Genomics, Inc.|NTLA: Earnings per share increase in current year|Net earnings per share growth this year STOK (Stoke Corp)|Expected net earnings per share growth this year biolifesolutions.com|Earnings growth in current year WVE (Wave Life Sciences Ltd)|Expected net earnings per share growth this year Maze Therapeutics (MAZE)|SION: Net earnings per share growth this year|Expected net earnings per share growth this year Prime Medicine Bio PRME|TSHA: Earnings growth in current year|Earnings per share growth this year QURE|Net earnings per share growth this year MGTX|Earnings per share growth this year RGNX (REGENXBIO)|Earnings growth in current year SLDB|OCGN - Earnings per share growth rate in current year|Earnings per share growth in current year Pacific Biosciences of California PACB|BNTC: Earnings per share growth this year|DSGN - Earnings per share growth in current year|RCKT: Earnings per share growth in current year|FDMT - Net earnings per one share growth for the current year|Earnings per share growth rate in current year Lexeo Therapeutics Inc. (LXEO)|Earnings per share growth in current year Korro Bio Inc.|Editas Medicine (EDIT) - Expected net earnings per share growth this year|Earnings per share growth in current year Silence Therapeutics Inc. (SLN)|PRQR: Earnings per share trend in current year|Earnings growth in current year CDXS (codexis.com)|SGMO: Earnings per share growth this year|NAUT: Net earnings per share growth this year|Earnings per share growth rate in current year metagenomi.co|Precision BioSciences, Inc. (DTIL) - Earnings per share growth in current year|Earnings per share growth rate in current year Generation Bio Corp (GBIO)|Net earnings per share growth this year BOLD|exicuretx.com (XCUR) - Expected net earnings per share growth this year|Earnings growth in current year PHIO|Mustang Bio - Earnings per share growth this year|TransCode Therapeutics, Inc. - Net earnings per share growth this year|Expected net earnings per share growth this year Bionano Genomics, Inc. (BNGO)|APDN - Earnings per share growth in current year|Earnings per share increase in current year BLUE (Bluebird Bio)|ImmunoPrecise (IPA) - Earnings per share growth in current year|OMGA: Net earnings per one share growth for the current year|Earnings per share growth in current year Singular Genomics Systems, Inc.|Earnings growth in current year Regulus Therapeutics, Inc.|Net earnings per share growth this year SYRS (Syros)|TBIO - Earnings per share growth rate in current year|Earnings per share growth in current year TRACON Pharmaceuticals, Inc. TCON|Unity Biotechnology (UBX) - Earnings per share growth rate in current year